bpc-157 multiple sclerosis clinical trial humans Stable gastric pentadecapeptide BPC 157 for colitis and sclerosis: Healing of cysteamine‐colitis and colon‐colon‐ anastomosis - Sikiric - 2013 - The FASEB Journal The Hidden Risks of BPC‑157:

BPC-157 Molecular FormulaC62H98N16O22 Molecular Weight1419.53 g/mol CAS Number137525-51-0 Amino Acid SequenceGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB-500 Molecular FormulaC212H350N56O78S Molecular Weight4963.44 g/mol CAS Number77591-33-4 Amino Acid SequenceAc-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser Research Applications Investigated in preclinical models for combined angiogenic and cytoskeletal remodeling pathways

Several preclinical and early clinical studies have confirmed such proof of concept and provided encouraging results in terms of regenerative effects and LBP reduction, respectively

Maintains Healthy Nervous System Function Thiamine (B1) and Pyridoxine (B6) contribute to normal nerve function and neurotransmitter synthesis, supporting neurological health

In some instances, this may result in additional scarring

Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O'Brien J, Jayson MIV